Kennedy Capital Management’s Viridian Therapeutics VRDN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-11,456	Closed	-$959K	–	744
2018 Q3	$959K	Sell	11,456 -123	-1%	-$10.3K	0.02%	647
2018 Q2	$1.11M	Buy	+11,579	New	+$1.11M	0.02%	662